A study of rare gynecological tumors
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at very rare types of female reproductive system tumors. It collects tissue samples to better understand these cancers. You may join if you have one of these rare tumors and have had surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a rare type of gynecological tumor, such as clear cell carcinoma, sarcoma, or germ cell tumor.
- You have already had surgery to remove the tumor and received the pathology results.
- You are willing to participate in the study and sign a consent form.
- You agree to have your tissue samples tested for genetic information.
- You do not have cancer in other parts of the body.
- You do not have severe mental health conditions or other illnesses that would make it hard to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is collecting tissue and blood samples from people with rare gynecologic cancers (like certain ovarian tumors, uterine sarcomas, and vulvar cancer) to understand their genetic makeup. The goal is to find better ways to manage and treat these rare cancers in the future.
This study is looking at people with rare cancers affecting the female reproductive system. It may help researchers learn more about how these cancers behave and how best to follow patients over time.
This study tests a new approach called SmartMatch that looks at the unique traits of your tumor to find the best treatment for you. The goal is to see if this personalized approach is feasible and helpful for people with rare gynecologic cancers.
This study looks at metastatic ovarian cancer by analyzing many types of patient data (from “multi-omics,” which means different kinds of lab and biological information). It may help doctors better understand the disease and improve future care.
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
This study follows people (and sometimes family members) connected to rare solid tumors and collects health information and samples (biospecimens). It helps researchers understand how these cancers develop and builds resources for future research, which may benefit you by contributing to better tailored care for rare cancers.
Hear when a new Rare Gynecological Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.